| 08:00-08:20 | 专题发言 |
胃癌Claudin18.2临床检测专家共识(2025版) |
|
||||
| 08:20-08:30 | 发言交流 |
An end-to-end synergistic model for personalized neoadjuvant immunochemotherapy decision-making in esophageal cancer |
|
||||
| 08:30-08:40 | 发言交流 |
M2 tumor-associated macrophages mediate the stemness and epithelial-mesenchymal transformation of esophageal squamous cell carcinoma through the TGF-β1-EZH2-smad2/3 pathway |
|
||||
| 08:40-08:50 | 发言交流 |
P53、Ki-67、FHL3及CSRP2在胃早期分化型管状腺癌中的表达与诊断意义 |
|
||||
| 08:50-09:00 | 发言交流 |
Prognostic Prediction of Pathological Evaluation Extramural Perivenous Infiltration in Patients with Locally Advanced Gastric Cancer |
|
||||
| 09:00-09:10 | 发言交流 |
新兴分子靶点CLDN18.2、FGFR2b和CDH17蛋白在进展或晚期胃癌中表达的时空差异性分析 |
|
||||
| 09:10-09:20 | 发言交流 |
METTL3 免疫组化在原发性小肠淋巴瘤活检病理诊断中的应用价值 |
|
||||
| 09:20-09:30 | 发言交流 |
非嗜酸粒细胞性食管炎的嗜酸性粒细胞胃肠道疾病 的病理诊断特征分析 |
|
||||
| 09:50-10:00 | 发言交流 |
林奇综合征多发癌的时空多组学与临床病理特征研究 |
|
||||
| 10:00-10:10 | 发言交流 |
Long noncoding RNA LBX2-AS1 promotes SCL1A5-mediated glutamine metabolism and cell proliferation in colorectal cancer |
|
||||
| 10:10-10:20 | 发言交流 |
The role of cancer stem cells in the progression of colorectal cancer and the tumor microenvironment: New perspectives from single-cell RNA sequencing and spatial transcriptomics analyses |
|
||||
| 10:20-10:30 | 发言交流 |
胰腺导管腺癌p53及Smad4免疫组化表达特点及二代测序技术验证 |
|
||||
| 10:30-10:40 | 发言交流 |
奥沙利铂引发肝脏结节型病变的病理特征分析 |
|
||||
| 10:40-10:50 | 发言交流 |
肝细胞癌与肝内胆管癌新辅助治疗后病理缓解程度存在显著差异 |
|
||||
| 10:50-11:00 | 发言交流 |
肝内胆管癌中肿瘤周围Glisson's鞘侵犯(PGSI)的 病理学评估及其临床意义 |
|
||||
| 11:00-11:10 | 发言交流 |
Epstein–Barr virus-associated intrahepatic cholangiocarcinoma presenting extremely wide morphological spectrum and correlating with the prognosis of patients |
|
||||
| 11:10-11:20 | 发言交流 |
脂肪性肝炎型肝细胞癌(SH-HCC)的临床病理及代谢特征分析 |
|
||||
| 11:20-11:25 | 总结 |
总结 |
|
||||